The Philippines: Accession to the Madrid Protocol is valid

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

The Philippines: Accession to the Madrid Protocol is valid

On July 19 2016, the Supreme Court (SC), in GR 204605, entitled Intellectual Property Association of the Philippines (IPAP) v Hon. Paquito Ochoa, in his capacity as Executive Secretary, et al, ruled that the Madrid Protocol is an executive agreement and that its ratification by President Aquino is valid and constitutional.

The IPAP, an association of IP law practitioners, filed the action seeking to declare the accession of the Philippines to the Madrid Protocol unconstitutional on the ground of lack of concurrence by the Senate, and because it conflicts with Section 125 of RA 8293 (the IP Code), on the necessity of appointing a resident agent to represent a foreign trade mark applicant.

The SC distinguished between treaties and international agreements which require the Senate's concurrence, and executive agreements which may be validly entered into without the Senate's concurrence. The SC noted that agreements with respect to the registration of trade marks have been concluded by the executive with various countries without the Senate's concurrence. Citing the declaration of state policy with respect to intellectual property as stated in the IP Code, the SC held that the IPAP was mistaken in asserting that there was no congressional act that authorised accession of the Philippines to the Madrid Protocol.

The SC also held that there was no conflict between the Madrid Protocol and the IP Code. The method of registration through the Intellectual Property Office of the Philippines (IPOPHL) as expressly stated in the IP Code is distinct and separate from the method of registration through the WIPO. The IPOPHL requires the designation of a resident agent when it refuses the registration of a mark, and when filing the declaration of actual use.

The Madrid Protocol does not amend nor modify the IP Code since trade mark applications filed through the Madrid Protocol are examined under the provisions of the IP Code. The SC further held that IPAP misapprehends the procedure for examination under the Madrid Protocol, and that the difficulty claimed by IPAP is minimal or inexistent. Hence the SC dismissed the IPAP petition for lack of merit.

Hechanova_Editha-100

Editha R Hechanova


Hechanova & Co., Inc.Salustiana D. Ty Tower104 Paseo de Roxas AvenueMakati City 1229, PhilippinesTel: (63) 2 812-6561Fax: (63) 2 888-4290

editharh@hechanova.com.ph  

www.hechanova.com.ph

more from across site and SHARED ros bottom lb

More from across our site

The chief technology officer remit, which has been created as the firm is building its litigation team, will include expanding the use of AI in patent and legal work and automating manual processes
Former Hoyng Rokh Moneiger partner Laura Alonso, who brought her team to ECIJA in March, discusses plans to expand further and why ECIJA’s ‘IP DNA’ is helping broaden her work
Amita Haylock discusses building an integrated Asia practice as clients increasingly demand that firms combine IP, technology and data expertise
François Pochart, Grégoire Desrousseaux and Lionel Martin, long-standing figures in the firm’s patent litigation team, are set to help launch a Paris-based litigation offering
The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
Gift this article